We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Association between body mass index and three-year outcome of acute myocardial infarction.
- Authors
Park, Soyoon; Kim, Dae-Won; Lee, Kyusup; Park, Mahn-Won; Chang, Kiyuk; Jeong, Myung Ho; Ahn, Young Keun; Chae, Sung Chull; Ahn, Tae Hoon; Rha, Seung Woon; Kim, Hyo-Soo; Gwon, Hyeon Cheol; Seong, In Whan; Hwang, Kyung Kuk; Kim, Kwon-Bae; Cha, Kwang Soo; Oh, Seok Kyu; Chae, Jei Keon
- Abstract
Body mass index (BMI), as an important risk factor related to metabolic disease. However, in some studies higher BMI was emphasized as a beneficial factor in the clinical course of patients after acute myocardial infarction (AMI) in a concept known as the "BMI paradox." The purpose of this study was to investigate how clinical outcomes of patients treated for AMI differed according to BMI levels. A total of 10,566 patients in the Korea Acute Myocardial Infarction Registry-National Institutes of Health (KAMIR-NIH) from May 2010 to June 2015 were divided into three BMI groups (group 1: BMI < 22 kg/m2, group 2: ≥ 22 and < 26 kg/m2, and group 3: ≥ 26 kg/m2). The primary outcome was major adverse cardiac and cerebrovascular event (MACCE) at 3 years of follow-up. At 1 year of follow-up, the incidence of MACCE in group 1 was 10.1% of that in group 3, with a hazard ratio (HR) of 2.27, and 6.5% in group 2, with an HR of 1.415. This tendency continued up to 3 years of follow-up. The study demonstrated that lower incidence of MACCE in the high BMI group of Asians during the 3-year follow-up period compared to the low BMI group. The results implied higher BMI could exert a positive effect on the long-term clinical outcomes of patients with AMI undergoing percutaneous coronary intervention (PCI).
- Subjects
AMERICAN Megatrends Inc.; BODY mass index; OBESITY paradox; PERCUTANEOUS coronary intervention
- Publication
Scientific Reports, 2024, Vol 14, Issue 1, p1
- ISSN
2045-2322
- Publication type
Article
- DOI
10.1038/s41598-023-43493-0